Indeed, NRF2 activators, such as Sulfurophane, Epigallocatechin-3-gallate, and curcumin, represent a good option for the treatment of acute and chronic kidney disease [57,58,59,60,61]. This evidence concerns the gene NFE2L2 and chronic kidney disease.